Please login to the form below
Biogen expands digital safety platform Assessa
The MS technolgy pilot, a collaboration with Ixico, will now include pharmacoviglance reporting
Biogen has expanded work on its digital safety platform, which helps monitor MS patients for signs of the rare and potentially fatel brain infection progressive multifocal leukoencephalopathy (PML).
The pilot programme, a collaboration with tech firm Ixico, will now include pharmacoviglance reporting to monitor patients for previously unreported adverse reactions.
The partners - who have been in a collaborative agreement since October 2015 - developed the Assessa system to provide neurologists with second opinion reading services if there is a suspicion of PML.
Giulio Cerroni, chief executive officer of Ixico, said: “We are delighted to announce the expansion of this pilot involving clinical experts in specialist MS centres and Biogen.
“The Assessa PML digital platform is intended to provide technology and speciality services to physcians involved in delivering care to people living with MS.”
Biogen has invested £1.5m in the project, which is currently being piloted in five EU countries.
Share
Related Hub content
Featured jobs
- Director of Digital Communications, Healthcare communications, S...
-
Excellent Package
- Senior Health Economist, Market Access, SE UK, Six figure packag...
-
Six figure package
-
Head of Healthcare Consulting, SE UK
-
Excellent Package
-
Principal Medical Writer
-
Great salary and benefits
-
Account Director at PAREXEL MedCom
-
Competitive Salary
- Scientific Team Leader, Medical Education
-
£55, 000 – £70, 000 benefits
- Scientific Director, Medical Communications
-
£60 – 70, 000 benefits
-
Account Director
-
Salary TBC
-
Medical Editor
-
Great salary and benefits
- Account Director, Healthcare Communications
-
£50, 000 - £60, 000
- Digital Account Director – Healthcare Communications
-
£50 – 60, 000 benefits
- Strategy & Business Development Director, Pharmaceutical Mar...
-
Excellent Package
-
Editorial Director - BioScience
-
Competitive Salary
-
Business Unit Head. Medcomms
-
Excellent Package
Subscribe to our email news alerts
- Random42 Win Gold for Medical Animation at Cannes Corporate Awards 2017
- NICE backs GSK’s ‘bubble baby’ gene therapy
- Meetings
- GSK’s shingles vaccine Shingrix claims US approval
- Janssen’s ‘Interceptors’ and the quest to prevent diseases taking hold
- Over two thirds of UK residents don’t believe that the state will be able to provide for their healthcare needs in later life
PMHub
Lucid Group Communications Limited
We are industry-leading thinkers when it comes to education. We use the latest academic thinking on the psychology of behaviour...
Latest intelligence
- Tools for the digital world
- The next step for the pharma industry...
- How Can We Make Payer Communications Really Sing?
- With so many different influences at play in access decisions, how can we make sure we tap into what’s really driving payer decision-making. How do we go beyond the stated...
- Harnessing the power of core elements to optimise market access
- This article by John Spoors and Anton Abrahams focuses on optimising market access – the RJW and Solaris Health teams operate across all major markets, where the principles set out...
Quick links
Infographics
